Story perspectives

New Hope for KRAS-Positive Lung Cancer Treatments

11/29/2025

46 9

Summary

Story summary

KRAS-positive lung cancer involves mutations in the KRAS gene, with G12C as the most common mutation, affecting about 50% of cases.
Treatment options include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy, especially for G12C cases.
Surgical options range from lobectomy to pneumonectomy.
Immunotherapy shows promise, especially with chemotherapy, and researchers are exploring treatments for other KRAS mutations, such as azoldonrasib for G12D.

1 of 1

Story summary

KRAS-positive lung cancer involves mutations in the KRAS gene, with G12C as the most common mutation, affecting about 50% of cases.
Treatment options include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy, especially for G12C cases.
Surgical options range from lobectomy to pneumonectomy.
Immunotherapy shows promise, especially with chemotherapy, and researchers are exploring treatments for other KRAS mutations, such as azoldonrasib for G12D.